Production (Stage)
Gain Therapeutics, Inc.
GANX
$1.73
-$0.07-3.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.07M | 10.39M | 12.05M | 16.94M | 12.66M |
| Total Receivables | 886.60K | 765.80K | 373.70K | 313.20K | 249.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.19M | 450.90K | 1.32M | 1.29M | 952.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.15M | 11.60M | 13.74M | 18.54M | 13.86M |
|
|
|||||
| Total Current Assets | 11.15M | 11.60M | 13.74M | 18.54M | 13.86M |
| Net Property, Plant & Equipment | 281.20K | 323.30K | 401.20K | 449.80K | 496.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 126.30K | 134.30K | 156.30K | 158.10K | 169.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 65.20K | 63.80K | 66.90K | 49.40K | 49.40K |
| Total Assets | 11.62M | 12.12M | 14.37M | 19.20M | 14.58M |
|
|
|||||
| Total Accounts Payable | 2.15M | 946.30K | 1.10M | 2.05M | 1.41M |
| Total Accrued Expenses | 2.38M | 2.42M | 2.47M | 3.42M | 2.29M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 261.80K | 271.10K | 297.10K | 297.90K | 315.40K |
| Total Finance Division Other Current Liabilities | 235.80K | 270.70K | 729.00K | 759.70K | 989.40K |
| Total Other Current Liabilities | 235.80K | 270.70K | 729.00K | 759.70K | 989.40K |
| Total Current Liabilities | 5.03M | 3.91M | 4.59M | 6.52M | 5.00M |
|
|
|||||
| Total Current Liabilities | 5.03M | 3.91M | 4.59M | 6.52M | 5.00M |
| Long-Term Debt | 314.50K | 328.30K | 376.10K | 375.40K | 396.80K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 30.60K | 53.60K | 96.20K | 134.30K | 177.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 470.90K | 491.10K | 389.10K | 378.80K | 356.80K |
| Total Liabilities | 5.84M | 4.78M | 5.46M | 7.41M | 5.94M |
|
|
|||||
| Common Stock & APIC | 91.62M | 88.78M | 86.09M | 84.71M | 73.42M |
| Retained Earnings | -85.73M | -81.19M | -77.43M | -72.94M | -64.80M |
| Treasury Stock & Other | -119.90K | -247.50K | 242.80K | 12.50K | 21.90K |
| Total Common Equity | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.78M | 7.34M | 8.91M | 11.78M | 8.64M |
|
|
|||||